Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Epix Pharmaceuticals, a biopharmaceutical company, has announced that Chen Schor has resigned his position as chief business officer, effective March 23, 2009, to pursue other opportunities.
Subscribe to our email newsletter
Sheila DeWitt, Epix’s former head of business development and current vice president of discovery and manufacturing, will lead the company’s business development efforts going forward.
Dr DeWitt joined the management team of Epix in 2005 as the vice president of business development and strategic planning and transitioned to the role of vice president of discovery and manufacturing in 2007.
Elkan Gamzu, interim CEO of Epix, said: “We thank Chen for his contributions, particularly the roles he played as we established our collaborations with Amgen, GlaxoSmithKline and the Cystic Fibrosis Foundation, and we wish him well in his future endeavors. At the same time, we are extremely pleased to have such a talented team here at Epix and look forward to Sheila assuming a leadership role in our business development efforts.”